Brij Ph - search results

India - English - Central Drugs Standard Control Organization

cloxabrij 1*10c caps.

brij ph - caps. - 1*10c

United States - English - NLM (National Library of Medicine)

inbrija- levodopa capsule

acorda therapeutics, inc. - levodopa (unii: 46627o600j) (levodopa - unii:46627o600j) - inbrija is indicated for the intermittent treatment of off episodes in patients with parkinson's disease treated with carbidopa/levodopa. inbrija is contraindicated in patients currently taking a nonselective monoamine oxidase (mao) inhibitor (e.g., phenelzine and tranylcypromine) or who have recently (within 2 weeks) taken a nonselective mao inhibitor. hypertension can occur if these drugs are used concurrently [see drug interactions (7.1)]. risk summary there are no adequate data on the developmental risk associated with the use of inbrija in pregnant women. in animal studies, carbidopa/levodopa has been shown to be developmentally toxic (including teratogenic effects) [see data]. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the background risk of major birth defects and miscarriage for the indicated

European Union - English - EMA (European Medicines Agency)

inbrija

acorda therapeutics ireland limited - levodopa - parkinson disease - anti-parkinson drugs - inbrija is indicated for the intermittent treatment of episodic motor fluctuations (off episodes) in adult patients with parkinson’s disease (pd) treated with a levodopa/dopa-decarboxylase inhibitor.

India - English - Central Drugs Standard Control Organization

albend 1*1t tabs.

brij ph - tabs. - 1*1t

India - English - Central Drugs Standard Control Organization

b-moxyl 500mg.tabs. 10*10

brij ph - 10*10

India - English - Central Drugs Standard Control Organization

b-moxyl-bh 10*10 tabs.

brij ph - tabs. - 10*10

India - English - Central Drugs Standard Control Organization

bepenclox kid 10*10

brij ph - 10*10